Chemed (NYSE:CHE) Director Sells $602,553.51 in Stock

Chemed Corporation (NYSE:CHE) Director Andrea Lindell sold 1,347 shares of the business’s stock in a transaction dated Tuesday, June 9th. The shares were sold at an average price of $447.33, for a total value of $602,553.51. Following the completion of the transaction, the director owned 4,578 shares in the company, valued at $2,047,876.74. This trade represents a 22.73% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link.

Chemed Stock Performance

Shares of NYSE CHE opened at $419.07 on Friday. The business’s 50-day moving average price is $415.27 and its two-hundred day moving average price is $424.51. The company has a debt-to-equity ratio of 0.11, a current ratio of 0.85 and a quick ratio of 0.83. Chemed Corporation has a one year low of $365.20 and a one year high of $562.77. The company has a market capitalization of $5.56 billion, a P/E ratio of 22.84, a price-to-earnings-growth ratio of 1.58 and a beta of 0.54.

Chemed (NYSE:CHE) last issued its earnings results on Thursday, April 23rd. The company reported $5.65 EPS for the quarter, beating analysts’ consensus estimates of $5.30 by $0.35. Chemed had a return on equity of 27.18% and a net margin of 10.23%.The firm had revenue of $657.51 million for the quarter, compared to the consensus estimate of $659.22 million. During the same quarter in the previous year, the company posted $5.63 earnings per share. The business’s quarterly revenue was up 1.6% compared to the same quarter last year. Chemed has set its FY 2026 guidance at 24.000-24.75 EPS. Analysts anticipate that Chemed Corporation will post 22.3 earnings per share for the current fiscal year.

Chemed Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Tuesday, June 16th. Shareholders of record on Thursday, May 28th will be paid a $0.60 dividend. The ex-dividend date is Thursday, May 28th. This represents a $2.40 dividend on an annualized basis and a yield of 0.6%. Chemed’s payout ratio is 13.08%.

Institutional Trading of Chemed

Several large investors have recently made changes to their positions in CHE. Northwestern Mutual Wealth Management Co. boosted its stake in shares of Chemed by 2,444,879.3% during the 4th quarter. Northwestern Mutual Wealth Management Co. now owns 5,550,103 shares of the company’s stock worth $2,374,667,000 after acquiring an additional 5,549,876 shares in the last quarter. JPMorgan Chase & Co. boosted its stake in shares of Chemed by 122.7% during the 3rd quarter. JPMorgan Chase & Co. now owns 499,968 shares of the company’s stock worth $223,856,000 after acquiring an additional 275,423 shares in the last quarter. Norges Bank bought a new stake in shares of Chemed during the 4th quarter worth about $76,067,000. AQR Capital Management LLC boosted its stake in shares of Chemed by 89.2% during the 4th quarter. AQR Capital Management LLC now owns 325,579 shares of the company’s stock worth $139,302,000 after acquiring an additional 153,469 shares in the last quarter. Finally, Victory Capital Management Inc. lifted its position in shares of Chemed by 1,260.2% during the 4th quarter. Victory Capital Management Inc. now owns 117,685 shares of the company’s stock worth $50,353,000 after purchasing an additional 109,033 shares during the last quarter. Institutional investors own 95.85% of the company’s stock.

Wall Street Analyst Weigh In

A number of research analysts have commented on the company. Zacks Research upgraded Chemed from a “strong sell” rating to a “hold” rating in a research note on Monday, April 27th. Weiss Ratings upgraded Chemed from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Wednesday, April 29th. Wall Street Zen downgraded Chemed from a “buy” rating to a “hold” rating in a research note on Monday, June 8th. Oppenheimer decreased their price target on Chemed from $580.00 to $500.00 and set an “outperform” rating for the company in a research note on Friday, February 27th. Finally, Royal Bank Of Canada upped their price target on Chemed from $422.00 to $436.00 and gave the stock a “sector perform” rating in a research note on Monday, April 27th. Two equities research analysts have rated the stock with a Buy rating and four have given a Hold rating to the company. Based on data from MarketBeat.com, Chemed currently has an average rating of “Hold” and an average price target of $501.50.

Chemed Company Profile

Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.

The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.